Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 1 , Pages 55-63 , March 2009

Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote

  • Raisuddin Ali, MPharm

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Gaurav K. Jain, MPharm

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Zeenat Iqbal, PhD

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Sushma Talegaonkar, PhD

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Pragati Pandit, PhD

      Affiliations

    • Cipla Ltd., Mumbai, India
  • ,
  • Sunita Sule, BPharm

      Affiliations

    • Cipla Ltd., Mumbai, India
  • ,
  • Geena Malhotra, BPharm

      Affiliations

    • Cipla Ltd., Mumbai, India
  • ,
  • Roop K. Khar, PhD

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India
  • ,
  • Aseem Bhatnagar, MD

      Affiliations

    • Division of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, New Delhi, India
    • Corresponding Author InformationCorresponding author.
  • ,
  • Farhan J. Ahmad, PhD

      Affiliations

    • Faculty of Pharmacy, Department of Pharmaceutics, Hamdard University, New Delhi, India

Received 17 July 2007 ,Accepted 11 July 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(08)00094-4

doi: 10.1016/j.nano.2008.07.001

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 1 , Pages 55-63 , March 2009